Mon, Jan 26, 2015, 4:04 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • wilderguide wilderguide Oct 20, 2013 2:36 PM Flag

    Former EXEL employee review

     Posted 10/13/13 at Glassdoordotcom...

    “Efficient, goal-oriented company”
    "Senior Scientist (Former Employee)
    South San Francisco, CA
    I worked at Exelixis full-time for more than 8 years
    Pros – Excellent management. Smart and hard working people.
    Cons – Since everyone knows the top priority of the company and department, it is a little frustrated to be assigned to the low priority projects.
    Yes, I would recommend this company to a friend"

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I tried a few times to send you info. but Yahoo didn't post it? I'll try again I'm sure you'll enjoy BioCentury and BioCentury This Week the T.V. program site.Lots of info. and videos.
      Since 1993, BioCentury Publications, Inc. has been internationally recognized as the leading provider of value-added information, analysis and data for biotechnology and pharmaceutical companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of life science ventures.BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.BioCentury's Editorial and Research staff comprise industry-recognized business and science editors and writers. The Company's management team includes executives with backgrounds in international business, publishing, finance, and the biotech and pharmaceutical industries. I only wish it was free! Ciao

1.73+0.10(+6.13%)3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.